Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: Implications in human disease

Journal of Immunology

Volumn 191, Issue 11, 2013, Pages 5524-5541

  Cox, Carol J ^a   Sharma, Meenakshi ^b   Leckman, James F ^c,d   Zuccolo, Jonathan ^a   Zuccolo, Amir ^a   Kovoor, Abraham ^b   Swedo, Susan E ^d,e   Cunningham, Madeleine W ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DOPAMINE; DOPAMINE 2 RECEPTOR; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 24.3.1; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; BASAL GANGLION; BEHAVIOR DISORDER; CHOREA MINOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IN VIVO STUDY; MOUSE; NONHUMAN; PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STREPTOCOCCUS;

EID: 84888310329     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102592     Document Type: Article

References (84)

1. Stollerman, G. H. 2001. Rheumatic fever in the 21st century. Clin. Infect. Dis. 33: 806-814.
2. Marques-Dias, M. J., M. T. Mercadante, D. Tucker, and P. Lombroso. 1997. Sydenham's chorea. Psychiatr. Clin. North Am. 20: 809-820.
3. Taranta, A., and G. H. Stollerman. 1956. The relationship of Sydenham's chorea to infection with group A streptococci. Am. J. Med. 20: 170-175.
4. Taranta, A. 1959. Relation of isolated recurrences of Sydenham's chorea to preceding streptococcal infections. N. Engl. J. Med. 260: 1204-1210.
5. Kurlan, R., and E. L. Kaplan. 2004. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 113: 883-886.
6. Kurlan, R., D. Johnson, and E. L. Kaplan; Tourette Syndrome Study Group. 2008. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 121: 1188-1197.
7. Murphy, T. K., R. Kurlan, and J. Leckman. 2010. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J. Child Adolesc. Psychopharmacol. 20: 317-331.
8. Gause, C., C. Morris, S. Vernekar, C. Pardo-Villamizar, M. A. Grados, and H. S. Singer. 2009. Antineuronal antibodies in OCD: comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J. Neuroimmunol. 214: 118-124.
9. Murphy, T. K., E. A. Storch, A. B. Lewin, P. J. Edge, and W. K. Goodman. 2012. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J. Pediatr. 160: 314-319
10. Kirvan, C. A., S. E. Swedo, J. S. Heuser, and M.W. Cunningham. 2003. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 9: 914-920.
11. Kirvan, C. A., C. J. Cox, S. E. Swedo, and M. W. Cunningham. 2007. Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J. Immunol. 178: 7412-7421.
12. Kirvan, C. A., S. E. Swedo, D. Kurahara, and M. W. Cunningham. 2006. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity 39: 21-29.
13. Kirvan, C. A., S. E. Swedo, L. A. Snider, and M. W. Cunningham. 2006. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J. Neuroimmunol. 179: 173-179.
14. Brilot, F., V. Merheb, A. Ding, T. Murphy, and R. C. Dale. 2011. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 76: 1508-1513.
15. Bronze, M. S., and J. B. Dale. 1993. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J. Immunol. 151: 2820-2828.
16. Husby, G., I. van de Rijn, J. B. Zabriskie, Z. H. Abdin, and R. C. Williams, Jr. 1976. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J. Exp. Med. 144: 1094-1110.
17. Zabriskie, J. B. 1967. Mimetic relationships between group A streptococci and mammalian tissues. Adv. Immunol. 7: 147-188.
18. Zabriskie, J. B., K. C. Hsu, and B. C. Seegal. 1970. Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin. Exp. Immunol. 7: 147-159.
19. Zabriskie, J. B. 1985. Rheumatic fever: the interplay between host, genetics, and microbe. Lewis A. Conner memorial lecture. Circulation 71: 1077-1086.
20. Swedo, S. E. 1994. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 272: 1788-1791.
21. Perlmutter, S. J., S. F. Leitman, M. A. Garvey, S. Hamburger, E. Feldman, H. L. Leonard, and S. E. Swedo. 1999. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354: 1153-1158.
22. Swedo, S. E., H. L. Leonard, M. Garvey, B. Mittleman, A. J. Allen, S. Perlmutter, L. Lougee, S. Dow, J. Zamkoff, and B. K. Dubbert. 1998. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry 155: 264-271.
23. Swedo, S. E., H. L. Leonard, B. B. Mittleman, A. J. Allen, J. L. Rapoport, S. P. Dow, M. E. Kanter, F. Chapman, and J. Zabriskie. 1997. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am. J. Psychiatry 154: 110-112.
24. Swedo, S. E., J. L. Rapoport, D. L. Cheslow, H. L. Leonard, E. M. Ayoub, D. M. Hosier, and E. R. Wald. 1989. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am. J. Psychiatry 146: 246-249.
25. Swedo, S. E., H. L. Leonard, M. B. Schapiro, B. J. Casey, G. B. Mannheim, M. C. Lenane, and D. C. Rettew. 1993. Sydenham's chorea: physical and psychological symptoms of St Vitus dance. Pediatrics 91: 706-713.
26. Swedo, S. E., and P. J. Grant. 2005. Annotation: PANDAS: a model for human autoimmune disease. J. Child Psychol. Psychiatry 46: 227-234.
27. Giedd, J. N., J. L. Rapoport, M. J. Kruesi, C. Parker, M. B. Schapiro, A. J. Allen, H. L. Leonard, D. Kaysen, D. P. Dickstein, W. L. Marsh, et al. 1995. Sydenham's chorea: magnetic resonance imaging of the basal ganglia. Neurology 45: 2199-2202.
28. Singer, H. S., C. R. Loiselle, O. Lee, K. Minzer, S. Swedo, and F. H. Grus. 2004. Anti-basal ganglia antibodies in PANDAS. Mov. Disord. 19: 406-415.
29. Giedd, J. N., J. L. Rapoport, M. A. Garvey, S. Perlmutter, and S. E. Swedo. 2000. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am. J. Psychiatry 157: 281-283.
30. Allen, A. J., H. L. Leonard, and S. E. Swedo. 1995. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J. Am. Acad. Child Adolesc. Psychiatry 34: 307-311.
31. Shikhman, A. R., N. S. Greenspan, and M. W. Cunningham. 1994. Cytokeratin peptide SFGSGFGGGY mimics N-acetyl-beta-D-glucosamine in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response. J. Immunol. 153: 5593-5606.
32. Shikhman, A. R., and M. W. Cunningham. 1994. Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. J. Immunol. 152: 4375-4387.
33. Shikhman, A. R., N. S. Greenspan, and M. W. Cunningham. 1993. A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-beta-D-glucosamine. J. Immunol. 151: 3902-3913.
34. Conners, C. K., K. C. Wells, J. D. Parker, G. Sitarenios, J. M. Diamond, and J. W. Powell. 1997. A new self-report scale for assessment of adolescent psychopathology: factor structure, reliability, validity, and diagnostic sensitivity. J. Abnorm. Child Psychol. 25: 487-497.
35. Brimberg, L., I. Benhar, A. Mascaro-Blanco, K. Alvarez, D. Lotan, C. Winter, J. Klein, A. E. Moses, F. E. Somnier, J. F. Leckman, et al. 2012. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 37: 2076-2087.
36. Aplin, B. D., C. L. Keech, A. L. de Kauwe, T. P. Gordon, D. Cavill, and J. McCluskey. 2003. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model. J. Immunol. 171: 5890-5900.
37. Pogue, S. L., and C. C. Goodnow. 2000. Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors. J. Exp. Med. 191: 1031-1044.
38. Kim-Saijo, M., T. Akamizu, K. Ikuta, Y. Iida, K. Ohmori, K. Matsubara, Y. Matsuda, M. Suzuki, F. Matsuda, and K. Nakao. 2003. Generation of a transgenic animal model of hyperthyroid Graves' disease. Eur. J. Immunol. 33: 2531-2538.
39. Li, J., Y. Wang, Q. X. Li, Y. M. Wang, J. J. Xu, and Z.W. Dong. 1998. Cloning of 3H11 mAb variable region gene and expression of 3H11 human-mouse chimeric light Chain. World J. Gastroenterol. 4: 41-44.
40. Kowal, C., L. A. DeGiorgio, T. Nakaoka, H. Hetherington, P. T. Huerta, B. Diamond, and B. T. Volpe. 2004. Cognition and immunity; antibody impairs memory. Immunity 21: 179-188.
41. Dal Toso, R., B. Sommer, M. Ewert, A. Herb, D. B. Pritchett, A. Bach, B. D. Shivers, and P. H. Seeburg. 1989. The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J. 8: 4025-4034.
42. Krisher, K., and M. W. Cunningham. 1985. Myosin: a link between streptococci and heart. Science 227: 413-415.
43. Swerlick, R. A., M. W. Cunningham, and N. K. Hall. 1986. Monoclonal antibodies cross-reactive with group A streptococci and normal and psoriatic human skin. J. Invest. Dermatol. 87: 367-371.
44. Galvin, J. E., M. E. Hemric, K. Ward, and M. W. Cunningham. 2000. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J. Clin. Invest. 106: 217-224.
45. Cunningham, M. W., H. C. Meissner, J. S. Heuser, B. A. Pietra, D. K. Kurahara, and D. Y. Leung. 1999. Anti-human cardiac myosin autoantibodies in Kawasaki syndrome. J. Immunol. 163: 1060-1065.
46. Li, Y., J. S. Heuser, S. D. Kosanke, M. Hemric, and M. W. Cunningham. 2004. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J. Immunol. 172: 3225-3234.
47. Tang, L., R. D. Todd, A. Heller, and K. L. O'Malley. 1994. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268: 495-502.
48. Goodnow, C. C. 1992. Transgenic mice and analysis of B-cell tolerance. Annu. Rev. Immunol. 10: 489-518.
49. Putterman, C., B. Deocharan, and B. Diamond. 2000. Molecular analysis of the autoantibody response in peptide-induced autoimmunity. J. Immunol. 164: 2542-2549.
50. DeGiorgio, L. A., K. N. Konstantinov, S. C. Lee, J. A. Hardin, B. T. Volpe, and B. Diamond. 2001. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7: 1189-1193.
51. Lo Bianco, C., J. L. Ridet, B. L. Schneider, N. Deglon, and P. Aebischer. 2002. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 99: 10813-10818.
52. Pickel, V. M., T. H. Joh, and D. J. Reis. 1975. Ultrastructural localization of tyrosine hydroxylase in noradrenergic neurons of brain. Proc. Natl. Acad. Sci. USA 72: 659-663.
53. Beaulieu, J. M., and R. R. Gainetdinov. 2011. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63: 182-217.
54. De Mei, C., M. Ramos, C. Iitaka, and E. Borrelli. 2009. Getting specialized: presynaptic and postsynaptic dopamine D2 receptors. Curr. Opin. Pharmacol. 9: 53-58.
55. Anzalone, A., J. E. Lizardi-Ortiz, M. Ramos, C. De Mei, F. W. Hopf, C. Iaccarino, B. Halbout, J. Jacobsen, C. Kinoshita, M. Welter, et al. 2012. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J. Neurosci. 32: 9023-9034.
56. Gerfen, C. R., T. M. Engber, L. C. Mahan, Z. Susel, T. N. Chase, F. J. Monsma, Jr., and D. R. Sibley. 1990. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429-1432.
57. Sano, H., Y. Yasoshima, N. Matsushita, T. Kaneko, K. Kohno, I. Pastan, and K. Kobayashi. 2003. Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function. J. Neurosci. 23: 9078-9088.
58. Surmeier, D. J., L. Carrillo-Reid, and J. Bargas. 2011. Dopaminergic modulation of striatal neurons, circuits, and assemblies. Neuroscience 198: 3-18.
59. Graybiel, A. M. 2000. The basal ganglia. Curr. Biol. 10: R509-R511.
60. Kawaguchi, Y., C. J. Wilson, S. J. Augood, and P. C. Emson. 1995. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 18: 527-535.
61. Gerfen, C. R., K. A. Keefe, and E. B. Gauda. 1995. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15: 8167-8176.
62. Celver, J., M. Sharma, and A. Kovoor. 2010. RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors. J. Neurochem. 114: 739-749.
63. Celver, J., M. Sharma, and A. Kovoor. 2012. D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions. J. Neurochem. 120: 56-69.
64. Dale, R. C., V. Merheb, S. Pillai, D. Wang, L. Cantrill, T. K. Murphy, H. Ben-Pazi, S. Varadkar, T. D. Aumann, M. K. Horne, et al. 2012. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 135: 3453-3468.
65. Fukunaga, K., and N. Shioda. 2012. Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop. Mol. Neurobiol. 45: 144-152.
66. Yaddanapudi, K., M. Hornig, R. Serge, J. De Miranda, A. Baghban, G. Villar, and W. I. Lipkin. 2010. Passive transfer of Streptococcus -induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol. Psychiatry 15: 712-726.
67. Hoffman, K. L., M. Hornig, K. Yaddanapudi, O. Jabado, and W. I. Lipkin. 2004. A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. J. Neurosci. 24: 1780-1791.
68. Dale, R. C. 2005. Post-streptococcal autoimmune disorders of the central nervous system. Dev. Med. Child Neurol. 47: 785-791.
69. Shannon, K. M., and G. M. Fenichel. 1990. Pimozide treatment of Sydenham's chorea. Neurology 40: 186.
70. Demiroren, K., H. Yavuz, L. Cam, B. Oran, S. Karaaslan, and S. Demiroren. 2007. Sydenham's chorea: a clinical follow-up of 65 patients. J. Child Neurol. 22: 550-554.
71. Moretti, G., M. Pasquini, G. Mandarelli, L. Tarsitani, and M. Biondi. 2008. What every psychiatrist should know about PANDAS: a review. Clin. Pract. Epidemol Ment. Health 4: 13.
72. Sokol, M. S. 2000. Infection-triggered anorexia nervosa in children: clinical description of four cases. J. Child Adolesc. Psychopharmacol. 10: 133-145.
73. Pivonello, R., D. Ferone, G. Lombardi, A. Colao, S. W. Lamberts, and L. J. Hofland. 2007. Novel insights in dopamine receptor physiology. Eur. J. Endocrinol. 156(Suppl. 1): S13-S21.
74. Pollack, A. 2004. Coactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers, and theirs. Sci. STKE 2004: pe50.
75. Harris, K., and H. S. Singer. 2006. Tic disorders: neural circuits, neurochemistry, and neuroimmunology. J. Child Neurol. 21: 678-689.
76. Kowal, C., L. A. Degiorgio, J. Y. Lee, M. A. Edgar, P. T. Huerta, B. T. Volpe, and B. Diamond. 2006. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. USA 103: 19854-19859.
77. Hughes, E. G., X. Peng, A. J. Gleichman, M. Lai, L. Zhou, R. Tsou, T. D. Parsons, D. R. Lynch, J. Dalmau, and R. J. Balice-Gordon. 2010. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J. Neurosci. 30: 5866-5875.
78. Wolstencroft, E. C., G. Simic, N. thi Man, I. Holt, T. Lam, P. R. Buckland, and G. E. Morris. 2007. Endosomal location of dopamine receptors in neuronal cell cytoplasm. J. Mol. Histol. 38: 333-340.
79. Parton, R. G., and A. A. Richards. 2003. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 4: 724-738.
80. Sudhof, T. C. 2004. The synaptic vesicle cycle. Annu. Rev. Neurosci. 27: 509-547.
81. Lee, J. Y., P. T. Huerta, J. Zhang, C. Kowal, E. Bertini, B. T. Volpe, and B. Diamond. 2009. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat. Med. 15: 91-96.
82. Gardoni, F., E. Marcello, and M. Di Luca. 2009. Postsynaptic density-membrane associated guanylate kinase proteins (PSD-MAGUKs) and their role in CNS disorders. Neuroscience 158: 324-333.
83. Hasbi, A., B. F. O'Dowd, and S. R. George. 2011. Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol. Brain 4: 26.
84. Ben-Pazi, H., J. A. Stoner, and M. W. Cunningham. 2013. Dopamine receptor autoantibodies correlate with symptoms in Sydenham's Chorea. PLoS ONE 8: e73516.